MedPath

ACT REPAGLINIDE

ACT REPAGLINIDE

Dormant
DIN Number

02321491

Drug Class

Human

Market Date

Oct 18, 2010

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02321491
AIG Number0137035003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BX02 REPAGLINIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

REPAGLINIDEActive
Strength: 2 MG
Monograph: REPAGLINIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.